6don MSN
Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...
Tata Communications, Signature Global, Power Grid, GR Infraprojects, Welspun Specialty, and Kolte Patil are among the top ...
Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...
13don MSN
Stocks including Infosys, Bharat Electronics, Vedanta, BEML, Ola Electric, NHPC, NPTC Green, Zydus Life and Jaiprakash ...
Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...
Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...
Stocks to watch Zydus Life: The pharma company ... Adani Enterprises: The Adani Group has reportedly won the project worth ₹36,000 crore to redevelop Motilal Nagar in Mumbai. IREDA: The board of ...
Global MedTech Market attracts Zydus Interest; Company acquires French Device Maker for $326 million
New Delhi: Indian pharma major Zydus Lifesciences has entered into exclusive negotiations to acquire a majority stake in France-based orthopedic device maker Amplitude Surgical for up to €300 ...
Zydus Lifesciences Ltd. on Tuesday, March 11, said its board of directors approved the acquisition of 85.6% equity shares of Amplitude Surgical SA, France. In an exchange filing, the company said the ...
Zydus Lifesciences Limited has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical's ...
(Reuters) -India’s Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France’s Amplitude Surgical for 256.8 million euros (nearly $280 million) as part of its plans to expand further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results